Pilot scorecard
Culturelle scored 3 out of 6 for label disclosure under methodology v1.13, read from the label as captured on 2026-09-27.
30ct chewable variant, Amazon listing B007G7JP2O.
The single active carries an exact amount, Lactobacillus rhamnosus GG 26 mg (5 billion CFUs). No proprietary blend anywhere on the panel.
No standardization-dependent ingredient in the formula.
LGG is a strain designation, and it is the example the methodology itself uses for criterion 3. C4 0, and on dose rather than on any unit or disclosure technicality. The label delivers 5x10^9 CFU per day. Vanderhoof 1999 (PMID 10547243), the pediatric LGG trial, dosed 1x10^10 to 2x10^10 CFU/day in children aged 6 months to 10 years and found a significant reduction in antibiotic-associated diarrhoea. This product provides one quarter to one half of the trial dose. The clinical-doses.csv row for LGG was carrying a 2026-09-07 flag reading 'NOT YET VERIFIED against PubMed... verify before relying on it'; it was verified and replaced with a real range before this score was assigned.
No reasoning recorded.
No publicly accessible third-party certificate of analysis located 2026-09-27 (listing images, culturelle.com, site-scoped and open web search), consistent with the same finding for Culturelle Pro Strength on 2026-09-26. Recorded as a negative finding, not a claim that none exists.
Serving size 'One (1) Tablet' is stated but servings per container is absent from the Supplement Facts panel. The carton front reads '30 once daily chewable tablets', which is not the panel. Same failure as Culturelle Pro Strength, Seed DS-01, Nature's Bounty and NOW Probiotic-10.
Scores are read from the live label, captured by screenshot on the date shown. A score describes what the label discloses. It says nothing about whether the product works, and nothing here was lab-tested.
